
Robert Hoffman
SelectiveNamed in filings at Chescappvt
- Board seats filed
- 9
all filings on record

Named in filings at Chescappvt
all filings on record
last 24 months
from a verified or cited source
| CCC Friends II Limited Partnership | Not yet classified | — | Earthshot Ventures |
| CytoDyn | Biotech & pharma | January 2026 | None on file |
| FibroBiologics | Biotech & pharma | November 2025 | None on file |
| ASLAN Pharmaceuticals | Biotech & pharma | February 2023 | None on file |
| Kintara Therapeutics | Biotech & pharma | August 2020 | None on file |
| ClearSign Technologies | Climate & energy | July 2018 | None on file |
| ANAPTYSBIO | Not yet classified | July 2015 | Frazier Life Sciences |
| MABVAX THERAPEUTICS HOLDINGS | Biotech & pharma | March 2015 | None on file |
| CombiMatrix | Digital health | June 2014 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Robert Hoffman on the board, based on 7 filed seats with a verified or cited source.
2 more filed seats not yet classified, left out of the shares above.